Factors predicting hemorrhagic complications after multimodal reperfusion therapy for acute ischemic stroke.
OBJECTIVE
We sought to find predictors for hemorrhagic complications in patients with acute ischemic stroke treated with multimodal endovascular therapy.


METHODS
We retrospectively reviewed patients with acute ischemic stroke treated with multimodal endovascular therapy from May 1999 to March 2006. We reviewed clinical and angiographic data, admission CT Alberta Stroke Programme Early CT Score (ASPECTS), and the therapeutic endovascular interventions used. Posttreatment CT scans were reviewed for the presence of a parenchymal hematoma or hemorrhagic infarction based on defined criteria. Predictors for these types of hemorrhages were determined by logistic regression analysis.


RESULTS
We identified 185 patients with a mean age of 65+/-13 years and mean National Institutes of Health Stroke Scale score of 17+/-4. Sixty-nine patients (37%) developed postprocedural hemorrhages: 24 (13%) parenchymal hematomas and 45 (24%) hemorrhagic infarctions. Patients with tandem occlusions (odds ratio [OR] 4.6 [1.4-6.5], P<.016), hyperglycemia (OR 2.8 [1.1-7.7], P<.043), or treated concomitantly with intravenous (IV) tissue plasminogen activator (tPA) and intra-arterial (IA) urokinase (OR 5.1 [1.1-25.0], P<.041) were at a significant risk for a parenchymal hematoma. Hemorrhagic infarction occurred significantly more in patients presenting with an ASPECTS<or=7 (OR 1.9 [1.3-2.7], P<.01).


CONCLUSIONS
Hemorrhagic infarctions are related to the extent of infarct based on presentation CT, whereas parenchymal hematomas are associated with the presence of tandem occlusions, hyperglycemia, and treatment with both IV tPA and IA urokinase in patients with acute stroke treated with multimodal endovascular therapy.
Vora
N A
NA
Department of Neurology, Stroke Institute, University of Pittsburgh, Medical Center, Pittsburgh, PA 15213, USA.
Gupta
R
R
Thomas
A J
AJ
Horowitz
M B
MB
Tayal
A H
AH
Hammer
M D
MD
Uchino
K
K
Wechsler
L R
LR
Jovin
T G
TG
D000208:Acute Disease; D000368:Aged; D002545:Brain Ischemia / Q000453:epidemiology* / Q000628:therapy*; D002543:Cerebral Hemorrhage / Q000453:epidemiology*; D015897:Comorbidity; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010414:Pennsylvania / Q000453:epidemiology; D015995:Prevalence; D015424:Reperfusion / Q000706:statistics & numerical data*; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors; D020521:Stroke / Q000453:epidemiology* / Q000628:therapy*; D016896:Treatment Outcome
AJNR Am J Neuroradiol. 1994 Mar;15(3):487-92
8197945
Stroke. 2006 Feb;37(2):556-61
16397182
Stroke. 2008 Dec;39(12):3283-7
18772441
Lancet. 2000 May 13;355(9216):1670-4
10905241
N Engl J Med. 1995 Dec 14;333(24):1581-7
7477192
Stroke. 2004 Jun;35(6):1323-8
15105521
Stroke. 2006 Apr;37(4):973-8
16497977
Stroke. 2001 Jun;32(6):1330-5
11387495
Stroke. 2004 Apr;35(4):904-11
15017018
Stroke. 2006 Oct;37(10):2526-30
16960093
Stroke. 2006 Apr;37(4):986-90
16527997
Stroke. 2005 Jul;36(7):1432-8
15961709
J Vasc Interv Radiol. 2002 Aug;13(8):769-74
12171979
Stroke. 1994 Feb;25(2):298-303
8303735
JAMA. 1999 Dec 1;282(21):2003-11
10591382